Erasca (ERAS) Other Non-Current Assets (2020 - 2026)

Erasca (ERAS) reported Other Non-Current Assets of $1.4 million for Q1 2026, down 44.7% on a YoY basis from $2.6 million in Q1 2025, and up 254.41% quarter-over-quarter from $408000.0 in Q4 2025.

Erasca (ERAS) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Erasca has reported Other Non-Current Assets for 7 years, with the latest figure at $1.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 44.7% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 44.7% YoY), and the FY2025 full-year result was $408000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $1.4 million, up from $408000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $4.4 million in Q3 2023, with the low at $408000.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $408000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets surged 975.49% — and 2024, when it plunged 90.69%.
  • Erasca's Other Non-Current Assets stood at $408000.0 in 2022, then soared by 974.26% to $4.4 million in 2023, then sank by 90.69% to $408000.0 in 2024, then changed by 0.0% to $408000.0 in 2025, then jumped by 254.41% to $1.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.4 million (Q1 2026), $408000.0 (Q4 2025), and $408000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Erasca 4.16 Bn 3.92 Bn - 1.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.45 Mn
Dec 31, 2025 408,000.00
Sep 30, 2025 408,000.00
Jun 30, 2025 408,000.00
Mar 31, 2025 2.62 Mn
Dec 31, 2024 408,000.00
Sep 30, 2024 3.88 Mn
Jun 30, 2024 408,000.00
Mar 31, 2024 408,000.00
Dec 31, 2023 4.38 Mn
Sep 30, 2023 4.39 Mn
Jun 30, 2023 408,000.00
Mar 31, 2023 408,000.00
Dec 31, 2022 408,000.00
Sep 30, 2022 408,000.00
Jun 30, 2022 408,000.00
Mar 31, 2022 408,000.00
Dec 31, 2021 2.91 Mn
Sep 30, 2021 408,000.00
Jun 30, 2021 408,000.00